Nucleic acid-based therapeutics for the treatment of central nervous system disorders by Robyn McCartan, Robyn McCartan, Olga Khorkova, Olga Khorkova, Claude-Henry Volmar, Claude-Henry Volmar, Claes Wahlestedt, Claes Wahlestedt

Get full text

Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse by Jessica Dennison, Armando Mendez, Angela Szeto, Ines Lohse, Claes Wahlestedt, Claude-Henry Volmar

Get full text

Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease by Roshni C. Lalwani, Claude-Henry Volmar, Claes Wahlestedt, Keith A. Webster, Lina A. Shehadeh

Get full text

Correction: Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM) by Christopher Kemper, Dariush Behnam, Shaun Brothers, Claes Wahlestedt, Claude-Henry Volmar, Daniel Bennett, Marshall Hayward

Get full text

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM) by Christopher Kemper, Dariush Benham, Shaun Brothers, Claes Wahlestedt, Claude-Henry Volmar, Daniel Bennett, Marshall Hayward

Get full text

Natural antisense transcripts as drug targets by Olga Khorkova, Jack Stahl, Aswathy Joji, Aswathy Joji, Claude-Henry Volmar, Zane Zeier, Claes Wahlestedt, Claes Wahlestedt

Get full text

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma. by Ines Lohse, Hassan Al-Ali, Claude-Henry Volmar, Annamil D Alvarez Trotta, Shaun P Brothers, Anthony J Capobianco, Claes Wahlestedt

Get full text

A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function follow... by Farzaneh Modarresi, Roya Pedram Fatemi, Seyedeh Fatemeh Razavipour, Natalie Ricciardi, Madina Makhmutova, Nathalie Khoury, Marco Magistri, Claude-Henry Volmar, Claes Wahlestedt, Mohammad Ali Faghihi

Get full text

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease by James A Timmons, Andrew Anighoro, Robert J Brogan, Jack Stahl, Claes Wahlestedt, David Gordon Farquhar, Jake Taylor-King, Claude-Henry Volmar, William E Kraus, Stuart M Phillips

Get full text

Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancerResearch in context by Sushmita Mustafi, Vladimir Camarena, Rehana Qureshi, Hyunho Yoon, Claude-Henry Volmar, Tyler C. Huff, David W. Sant, Lihong Zheng, Shaun P. Brothers, Claes Wahlestedt, Joyce Slingerland, Gaofeng Wang

Get full text

Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq by Tanner Stokes, Haoning Howard Cen, Philipp Kapranov, Iain J Gallagher, Andrew A. Pitsillides, Claude‐Henry Volmar, William E Kraus, James D. Johnson, Stuart M. Phillips, Claes Wahlestedt, James A. Timmons

Get full text

Bruton’s tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax by Caroline A. Coughlin, Dhanvantri Chahar, Marianna Lekakis, Abdessamad A. Youssfi, Lingxiao Li, Evan Roberts, Natalia Campos Gallego, Claude-Henry Volmar, Ola Landgren, Shaun Brothers, Anthony J. Griswold, Catalina Amador, Daniel Bilbao, Francesco Maura, Jonathan H. Schatz

Get full text

Drug and disease signature integration identifies synergistic combinations in glioblastoma by Vasileios Stathias, Anna M. Jermakowicz, Marie E. Maloof, Michele Forlin, Winston Walters, Robert K. Suter, Michael A. Durante, Sion L. Williams, J. William Harbour, Claude-Henry Volmar, Nicholas J. Lyons, Claes Wahlestedt, Regina M. Graham, Michael E. Ivan, Ricardo J. Komotar, Jann N. Sarkaria, Aravind Subramanian, Todd R. Golub, Stephan C. Schürer, Nagi G. Ayad

Get full text